Wellington Management Group LLP Purchases 1,413 Shares of McKesson Co. (NYSE:MCK)

Wellington Management Group LLP boosted its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 18.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,179 shares of the company's stock after purchasing an additional 1,413 shares during the period. Wellington Management Group LLP's holdings in McKesson were worth $5,231,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of MCK. Capital A Wealth Management LLC bought a new position in shares of McKesson during the 4th quarter worth approximately $26,000. Millstone Evans Group LLC bought a new position in shares of McKesson during the 4th quarter worth approximately $28,000. Atala Financial Inc bought a new position in shares of McKesson during the 4th quarter worth approximately $34,000. Graney & King LLC bought a new position in shares of McKesson during the 4th quarter worth approximately $38,000. Finally, Creative Capital Management Investments LLC bought a new position in shares of McKesson during the 4th quarter worth approximately $44,000. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the firm's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $726.51, for a total value of $394,494.93. Following the completion of the transaction, the chief accounting officer now owns 1,972 shares in the company, valued at $1,432,677.72. This trade represents a 21.59% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Thomas L. Rodgers sold 2,891 shares of the firm's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $712.18, for a total transaction of $2,058,912.38. Following the transaction, the executive vice president now directly owns 2,544 shares of the company's stock, valued at $1,811,785.92. The trade was a 53.19% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 13,747 shares of company stock worth $9,852,587. 0.11% of the stock is currently owned by insiders.

McKesson Trading Up 0.2%

McKesson stock traded up $1.20 during midday trading on Thursday, reaching $710.66. The company's stock had a trading volume of 614,234 shares, compared to its average volume of 914,545. The stock has a market cap of $88.91 billion, a PE ratio of 32.54, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53. McKesson Co. has a 52 week low of $464.42 and a 52 week high of $731.00. The business has a 50-day moving average price of $698.17 and a 200-day moving average price of $639.78.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to analysts' expectations of $94 billion. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm's quarterly revenue was up 18.9% compared to the same quarter last year. During the same period in the prior year, the company earned $6.18 EPS. As a group, research analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be issued a $0.71 dividend. The ex-dividend date of this dividend is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.40%. McKesson's payout ratio is presently 10.99%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on MCK shares. Morgan Stanley lifted their target price on McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 2nd. Wells Fargo & Company lifted their target price on McKesson from $691.00 to $766.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Wall Street Zen upgraded McKesson from a "buy" rating to a "strong-buy" rating in a research note on Friday, May 30th. Cfra Research cut McKesson from a "moderate buy" rating to a "hold" rating in a report on Friday, April 4th. Finally, Mizuho lifted their price target on McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a report on Thursday, April 3rd. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $692.46.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.